Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core Scientific Inc (CORZ) vs First Citizens BancShares Inc (FCNCA) Price & Performance

Core Scientific IncTrade
First Citizens BancShares IncTrade

Price performance (Past 24H)

Key statistics

Core Scientific Inc vs First Citizens BancShares Inc — how do they compare? Core Scientific Inc trades at $19.79 (market cap $6.71B), while First Citizens BancShares Inc trades at $2,270.53 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 3.8× Core Scientific Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.

CORZFCNCA
Market Cap
$6.71B$25.26B
Sector
TechnologySector/Thematic
52-Week High
$29.16$2.27K
52-Week Low
$13.55$1.64K
Enterprise Value
$9.23B
Dividend Yield
0.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Core Scientific Inc

Core Scientific (CORZ) trades at $20.87, up 7.36% today, amid strong analyst support with 19 buy ratings and a $35.88 consensus price target. The stock shows bearish technical signals with resistance at $21, while fundamentals reveal significant losses (-$288.62M net income in 2025) despite revenue growth to $319M. Recent AMD partnership for 2.5GW data center capacity signals strategic pivot to AI infrastructure.

Outlook balances high growth potential from AI contracts against substantial cash burn and negative margins. Key risks include execution of expansion plans and profitability timeline, but institutional interest and analyst optimism suggest upside if operational targets are met.

First Citizens BancShares Inc

First Citizens BancShares (FCNCA) trades at $2,271.31, up 1.7% on the day, with a bullish technical signal from moving averages and recent earnings beats. The stock shows strong fundamentals with a P/E of 12.08 and net income margin of 25.23%, supported by consistent revenue around $9.3B. Recent news highlights expansion in commercial lending and strategic leadership appointments, reinforcing growth initiatives.

Outlook remains positive due to earnings momentum and dividend stability, but risks include elevated uninsured deposits and net interest margin pressure. Analyst consensus is cautious with 82% hold ratings, suggesting limited near-term upside despite a $2,310 price target. Investors should weigh solid profitability against sector headwinds and valuation constraints.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.

Read more on CORZ

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.

Read more on FCNCA